{"id":39319,"date":"2016-11-14T00:00:00","date_gmt":"2016-11-13T23:00:00","guid":{"rendered":"http:\/\/www.pcb.ub.edu\/\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/"},"modified":"2020-11-16T16:23:28","modified_gmt":"2020-11-16T15:23:28","slug":"el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/","title":{"rendered":"El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias"},"content":{"rendered":"<p>Jordi Quintana, responsable de Desarrollo de Negocio del Parc Cient\u00edfic de Barcelona (PCB) y\u00a0Francesc Palau,\u00a0director del\u00a0Institut de Recerca Pedi\u00e0trica-Hospital Sant Joan de D\u00e9u (IRP-HSJD), co-lideran este foro de debate interdisciplinario e internacional, donde cient\u00edficos de los \u00e1mbitos de la qu\u00edmica, \u00a0la computaci\u00f3n, \u00a0la biolog\u00eda,y \u00a0la gen\u00f3mica, intercambiar\u00e1n experiencias y conocimientos con expertos cl\u00ednicos en enfermedades raras y representantes de agencias y entidades p\u00fablicas y privadas para encontrar nuevas terapias en beneficio de los pacientes.<\/p>\n<p>En el mundo hay unas 7.000 patolog\u00edas minoritarias diferentes, que afectan a un 6-8% de la poblaci\u00f3n global, seg\u00fan Orphanet. La gran parte de ellas aparecen\u00a0durante la \u00e9poca de la ni\u00f1ez y acostumbran a ser enfermedades gen\u00e9ticas graves \u2013a menudo mortales\u2013, con s\u00edntomas muy discapacitantes para la persona que las sufre.<\/p>\n<p>Hoy en d\u00eda s\u00f3lo un 5% de estas patolog\u00edas tienen tratamiento, y su poca prevalencia supone un <em>handicap<\/em> a la hora de desarrollar otros nuevos. Adem\u00e1s, el proceso de descubrimiento de nuevos medicamentos es largo y costoso, y una posible estrategia para realizarlo de forma\u00a0m\u00e1s r\u00e1pida y eficiente es el reposicionament de f\u00e1rmacos (<em>drug repurposing<\/em>); es decir, encontrar nuevas aplicaciones terap\u00e9uticas de medicamentos ya existentes o de compuestos que hayan superado los ensayos en pacientes.<\/p>\n<p>Actualmente hay unos 8.000 f\u00e1rmacos al mercado o en fases cl\u00ednicas que, gracias al reposicionamento, podr\u00edan convertirse en una prometedora alternativa terap\u00e9utica para curar las enfermedades minoritarias, frenar su progresi\u00f3n o mejorar su pron\u00f3stico, aumentando la supervivencia y calidad de vida de los pacientes.<\/p>\n<p>\u00a0<\/p>\n<p><strong>\u2022 Programa del\u00a0<em>B\u00b7Debate: Drug Repurposing for Rare Diseases<\/em>\u00a0<a href=\"http:\/\/www.bdebate.org\/ca\/debat\/drug-repurposing-rare-diseases-cure-21st-century\">[+info]<\/a><\/strong><\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bajo el lema\u00a0<em><a href=\"http:\/\/www.bdebate.org\/ca\/debat\/drug-repurposing-rare-diseases-cure-21st-century\">Drug repurposing for rare diseases. The cure for the 21st century<\/a><\/em>,\u00a0el 17 y18 de noviembre\u00a0<a href=\"http:\/\/www.bdebate.org\/ca\" target=\"_blank\" rel=\"noopener noreferrer\">B\u00b7Debate<\/a>\u00a0\u2013 una iniciativa de\u00a0<a href=\"http:\/\/www.pcb.ub.edu\/portal\/es\/cerca?p_p_id=cercador_WAR_empleatsempresesportlet&amp;p_p_lifecycle=0&amp;p_p_state=maximized&amp;p_p_mode=view&amp;p_p_col_id=column-1&amp;p_p_col_count=1&amp;_cercador_WAR_empleatsempresesportlet_jspPage=%2Fhtml%2Fcommon%2Fdetall-empresa.jsp&amp;_cercador_WAR_empleatsempresesportlet_empresaId=ENT_003738&amp;_cercador_WAR_empleatsempresesportlet_redirect=%2Fportal%2Fca%2Fcerca%3Fp_p_id%3Dcercador_WAR_empleatsempresesportlet%26p_p_lifecycle%3D0%26p_p_mode%3Dview%26_cercador_WAR_empleatsempresesportlet_keywords%3Dbiocat%26_cercador_WAR_empleatsempresesportlet_tab%3D1\" target=\"_blank\" rel=\"noopener noreferrer\">Biocat\u00a0<\/a>y la\u00a0<a href=\"https:\/\/obrasociallacaixa.org\/es\/home\" target=\"_blank\" rel=\"noopener noreferrer\">Obra Social \u201cla Caixa\u201d<\/a>\u2013 convoca, conjuntamente con\u00a0el\u00a0Parc Cient\u00edfic de Barcelona (PCB)\u00a0y el Hospital Sant Joan de D\u00e9u (<a href=\"https:\/\/www.sjdhospitalbarcelona.org\/es\" target=\"_blank\" rel=\"noopener noreferrer\">HSJD<\/a>),\u00a0un encuentro internacional de expertos en Cosmocaixa con el objetivo de identificar nuevas estrategias terap\u00e9uticas para las enfermedades minoritarias, con especial \u00e9nfasis en el reposicionamento de f\u00e1rmacos ya existentes para otras patolog\u00edas.<\/p>\n<p>\u00a0<\/p>\n","protected":false},"author":1,"featured_media":27702,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[9],"tags":[],"class_list":["post-39319","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sin-categorizar"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Bajo el lema\u00a0Drug repurposing for rare diseases. The cure for the 21st century,\u00a0el 17 y18 de noviembre\u00a0B\u00b7Debate\u00a0\u2013 una iniciativa de\u00a0Biocat\u00a0y la\u00a0Obra Social \u201cla Caixa\u201d\u2013 convoca, conjuntamente con\u00a0el\u00a0Parc Cient\u00edfic de Barcelona (PCB)\u00a0y el Hospital Sant Joan de D\u00e9u (HSJD),\u00a0un encuentro internacional de expertos en Cosmocaixa con el objetivo de identificar nuevas estrategias terap\u00e9uticas para las enfermedades minoritarias, con especial \u00e9nfasis en el reposicionamento de f\u00e1rmacos ya existentes para otras patolog\u00edas. \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-13T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-16T15:23:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2016\/11\/16049228895fa92e09d3cb8.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"352\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adminpcb\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminpcb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/\"},\"author\":{\"name\":\"adminpcb\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"headline\":\"El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias\",\"datePublished\":\"2016-11-13T23:00:00+00:00\",\"dateModified\":\"2020-11-16T15:23:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/\"},\"wordCount\":300,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/16049228895fa92e09d3cb8.jpeg\",\"articleSection\":[\"Sin categorizar\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/\",\"name\":\"El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/16049228895fa92e09d3cb8.jpeg\",\"datePublished\":\"2016-11-13T23:00:00+00:00\",\"dateModified\":\"2020-11-16T15:23:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/16049228895fa92e09d3cb8.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/16049228895fa92e09d3cb8.jpeg\",\"width\":800,\"height\":352},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\",\"name\":\"adminpcb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"caption\":\"adminpcb\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/adminpcb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/","og_locale":"es_ES","og_type":"article","og_title":"El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias - Parc Cient\u00edfic de Barcelona","og_description":"Bajo el lema\u00a0Drug repurposing for rare diseases. The cure for the 21st century,\u00a0el 17 y18 de noviembre\u00a0B\u00b7Debate\u00a0\u2013 una iniciativa de\u00a0Biocat\u00a0y la\u00a0Obra Social \u201cla Caixa\u201d\u2013 convoca, conjuntamente con\u00a0el\u00a0Parc Cient\u00edfic de Barcelona (PCB)\u00a0y el Hospital Sant Joan de D\u00e9u (HSJD),\u00a0un encuentro internacional de expertos en Cosmocaixa con el objetivo de identificar nuevas estrategias terap\u00e9uticas para las enfermedades minoritarias, con especial \u00e9nfasis en el reposicionamento de f\u00e1rmacos ya existentes para otras patolog\u00edas. \u00a0","og_url":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2016-11-13T23:00:00+00:00","article_modified_time":"2020-11-16T15:23:28+00:00","og_image":[{"width":800,"height":352,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2016\/11\/16049228895fa92e09d3cb8.jpeg","type":"image\/jpeg"}],"author":"adminpcb","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"adminpcb","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/"},"author":{"name":"adminpcb","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"headline":"El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias","datePublished":"2016-11-13T23:00:00+00:00","dateModified":"2020-11-16T15:23:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/"},"wordCount":300,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2016\/11\/16049228895fa92e09d3cb8.jpeg","articleSection":["Sin categorizar"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/","url":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/","name":"El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2016\/11\/16049228895fa92e09d3cb8.jpeg","datePublished":"2016-11-13T23:00:00+00:00","dateModified":"2020-11-16T15:23:28+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2016\/11\/16049228895fa92e09d3cb8.jpeg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2016\/11\/16049228895fa92e09d3cb8.jpeg","width":800,"height":352},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/el-reposicionamento-de-farmacos-una-nueva-esperanza-para-las-enfermedades-minoritarias\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"El reposicionamento de f\u00e1rmacos, una nueva esperanza para las enfermedades minoritarias"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021","name":"adminpcb","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","caption":"adminpcb"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/adminpcb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/39319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=39319"}],"version-history":[{"count":1,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/39319\/revisions"}],"predecessor-version":[{"id":45399,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/39319\/revisions\/45399"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/27702"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=39319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=39319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=39319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}